Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer genetics.

Alfred G Knudson1

  • 1Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. AG_Knudson@fccc.edu

American Journal of Medical Genetics
|July 19, 2002
PubMed
Summary
This summary is machine-generated.

Cancer arises from genetic mutations in somatic cells, often involving abnormal chromosomes. Research into hereditary cancers has identified over 30 genes, primarily tumor suppressors, crucial for understanding cancer development and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Oncotarget·2016
Same author

Revisiting tissue specificity of germline cancer predisposing mutations.

Nature reviews. Cancer·2015
Same author

My memories of Dr. Giovanni Neri.

American journal of medical genetics. Part A·2013
Same author

Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.

PloS one·2013
Same author

Dosage and tumour suppression.

The Journal of pathology·2012
Same author

A continuum model for tumour suppression.

Nature·2011

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Cancer is fundamentally a genetic disease originating from somatic cell mutations.
  • Tumor cells frequently exhibit abnormal chromosome numbers and structures (karyotypes).
  • Early evidence linked cancer to oncogenes and gene transcription regulation via tumor-specific translocations.

Purpose of the Study:

  • To explore the genetic basis of cancer, focusing on somatic and hereditary factors.
  • To highlight the role of oncogenes and tumor suppressor genes in cancer development.
  • To review recent advances in identifying human cancer genes and their implications for treatment.

Main Methods:

  • Analysis of tumor karyotypes to identify chromosomal abnormalities.
  • Studies of tumor-specific translocations in leukemias and lymphomas.

Related Experiment Videos

  • Cloning and characterization of mutant genes associated with hereditary cancer predisposition.

    • Main Results:

    • Over 30 mutant genes for hereditary cancers have been cloned in the last decade.
    • Identified genes include oncogenes, DNA repair genes, and predominantly tumor suppressor genes.
    • Tumor suppressor genes identified regulate transcription and signal transduction pathways controlling cell fate.

    Conclusions:

    • Genetic alterations, including chromosomal abnormalities and specific gene mutations, are central to cancer.
    • Understanding hereditary cancer genes, particularly tumor suppressors, provides critical insights into cancer etiology.
    • This knowledge is driving novel strategies for cancer treatment and prevention.